Additional agreement with Bio Vitos Medical brings forward the time for calling the extraordinary general meeting by one week
Hemcheck and Biovitos have signed an additional agreement which enables Hemcheck to send out a calling to the extra general shareholders meeting that will decide on the deal, one week later than what is stipulated in the agreement signed on February 7. The last day to send the calling is now set to March 28. The reason is purely administrative.For further information contact: Hemcheck Sweden AB (publ) Joen Averstad, acting CEO Tel: +46 76 108 8191 Email: joen.averstad@hemcheck.com About Hemcheck Hemcheck Sweden AB, founded in 2010, produces and commercializes a patented CE-